zheng791
☆    

US,
2018-07-13 21:31
(1289 d 02:16 ago)

Posting: # 19052
Views: 2,492
 

 Not using Bio­strength for BE [Regulatives / Guidelines]

Hi,
Our firm is developing a multi-strength product which is a high potency, NTI oral dosage. The highest strength is 0.3 mg. The product guidance requests to use 0.3 mg x2 tablets for dosing and biowaive the lower strengths. However, our firm does not want to develop 0.3 mg. They have 0.15 mg as highest strength. Can I use 0.15 mg x4 for dosing and biowaive lower strengths? These strengths are similarly proportional, that is have the same tablet weight, the filler weight changes to compensate the API change.

Thank you
ElMaestro
★★★

Denmark,
2018-07-13 22:29
(1289 d 01:19 ago)

@ zheng791
Posting: # 19055
Views: 2,135
 

 Not using Bio­strength for BE

Hi zheng791,

» Can I use 0.15 mg x4 for dosing and biowaive lower strengths?

No, unless you actively contact OGD and get a yes from them.

Pass or fail!
ElMaestro
jag009
★★★

NJ,
2018-07-17 06:32
(1285 d 17:15 ago)

@ zheng791
Posting: # 19073
Views: 1,992
 

 Not using Bio­strength for BE

Hi,

» Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...

1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence

J
sameep
☆    

India,
2018-07-17 06:46
(1285 d 17:01 ago)

@ zheng791
Posting: # 19076
Views: 2,048
 

 Not using Bio­strength for BE

» They have 0.15 mg as highest strength. Can I use 0.15 mg x4 for dosing and biowaive lower strengths?

The product in question needs to be dosed at 0.6 mg for getting measurable concentrations (endogenous substance, baseline correction,...).
Yes, 0.15 mg x 4 tablets can be dosed, Still get a controlled correspondence with FDA.
Activity
 Admin contact
21,835 posts in 4,569 threads, 1,554 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Saturday 22:48 CET (Europe/Vienna)

Science may set limits to knowledge,
but should not set limits to imagination.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5